transformující růstový faktor beta2 [Transforming Growth Factor beta2]
- Termíny
-
polyergin
TGF-beta-2
TGF-beta2
TGF-beta2LAP
-
BSC-1 Cell Growth Inhibitor
Cartilage-Inducing Factor-B
Glioblastoma-Derived T-Cell Suppressor Factor
Polyergin
Suppressor Factor, T-Cell, Glioblastoma-Derived
TGF-beta-2
TGF-beta2
TGF-beta2 Latency-Associated Protein
TGF-beta2LAP
Transforming Growth Factor beta 2 Latency Associated Peptide
A TGF-beta subtype that was originally identified as a GLIOBLASTOMA-derived factor which inhibits the antigen-dependent growth of both helper and CYTOTOXIC T LYMPHOCYTES. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta2 and TGF-beta2 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor.
- DUI
- D053781 MeSH Prohlížeč
- CUI
- M0024759
- Historická pozn.
- 2007(2000)
- Veřejná pozn.
- 2007; TRANSFORMING GROWTH FACTOR BETA2 was indexed under TRANSFROMING GROWTH FACTOR BETA 2000-2006
Povolená podhesla
- AG
- agonisté 0
- AN
- analýza 0
- AI
- antagonisté a inhibitory 0
- AD
- aplikace a dávkování 0
- BI
- biosyntéza 0
- CS
- chemická syntéza 0
- CH
- chemie 0
- HI
- dějiny 0
- EC
- ekonomika 0
- PK
- farmakokinetika 0
- PD
- farmakologie 1
- PH
- fyziologie 0
- GE
- genetika 1
- IM
- imunologie 0
- IP
- izolace a purifikace 0
- CL
- klasifikace 0
- BL
- krev 0
- ME
- metabolismus 4
- UR
- moč 0
- CF
- mozkomíšní mok 0
- DF
- nedostatek 0
- ST
- normy 0
- PO
- otrava 0
- AE
- škodlivé účinky 0
- TU
- terapeutické užití 0
- TO
- toxicita 0
- DE
- účinky léků 0
- RE
- účinky záření 0
- UL
- ultrastruktura 0
- SD
- zásobování a distribuce 0